Bend Research has added a new cGMP spray-drying facility, expanding its capabilities and expertise for the development and manufacture of high-potency drug candidates.   The new facility accommodates the manufacture of a range of compound types and safety classifications, ranging from inhalable biotherapeutics to oral solid high-potency small molecules. The facility is separated from the company’s other development and cGMP manufacturing facilities, and is designed for high containment operation...